Title
Correction: RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors(Clin Cancer Res. (2016)22:6 (1499-509) DOI: 10.1158/1078-0432.CCR-15-1125)
Date Issued
15 February 2019
Access level
open access
Resource Type
corrigendum
Author(s)
Loi S.
Dushyanthen S.
Beavis P.
Salgado R.
Denkert C.
Savas P.
Combs S.
Rimm D.
Giltnane J.
Estrada M.
Sanchez V.
Sanders M.
Cook R.
Pilkinton M.
Mallal S.
Wang K.
Miller V.
Stephens P.
Yelensky R.
Ryzhov S.
Darcy P.
Arteaga C.
Balko J.
Publisher(s)
American Association for Cancer Research Inc.
Abstract
In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Start page
1437
Volume
25
Issue
4
Language
English
OCDE Knowledge area
Oncología
Inmunología
Scopus EID
2-s2.0-85061565447
PubMed ID
Source
Clinical Cancer Research
ISSN of the container
10780432
Sources of information:
Directorio de Producción Científica
Scopus